Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study
about
Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancerThe efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancerLarge-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapyImprovement in quality of life for cancer patients treated with epoetin alfa.
P2860
Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study
@ast
Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study
@en
type
label
Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study
@ast
Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study
@en
prefLabel
Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study
@ast
Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study
@en
P2093
P2860
P356
P1476
Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1993.27
P407
P577
1993-01-01T00:00:00Z